Testing is the first line of defence against COVID-19 and the foundation for preparedness to prevent future pandemics
Watch the event hereData since 2015
71
clinical trials
undertaken
11
WHO recommendations supported
6,000+
health workers trained
32,500+
patients enrolled in studies
50m+
FIND-supported
products procured
3,000+
laboratories & testing
sites strengthened
FIND names Bill Rodriguez as new CEO to lead its new strategy
ReadDonation of 450,000 Abbott rapid diagnostic tests for sleeping sickness to endemic countries will galvanize efforts towards eliminating the disease
ReadFIND launches call for proposals to accelerate availability of low-cost self-testing solutions for COVID-19 in low- and middle-income countries
ReadMeet Sabir. He is 14 years old and lives in Surat, India. He loves studying and competed in the national Science Olympiad. He found out he had TB only after learning about the disease during a school visit by doctors.
Read
Zaza is a social worker at Imedi HRS in Batumi, Georgia. With a lab specialist, Zaza does community outreach work conducting mobile counseling and screening for hepatitis C and other infectious diseases, using a lab-in-a van.
Read
This is Jennifer from the Research Institute for Tropical Medicine (RITM) in the Philippines, leading a workshop in Addis Ababa, Ethiopia, on quality testing for malaria rapid tests.
Read
World Malaria Day is always a chance to reflect on progress made and remaining challenges as we strive for elimination of this deadly, yet treatable, disease. This year, one thing is crystal clear: we won’t get malaria elimination back on track while countries are also battling COVID-19: data reported by the Global Fund this month indicate that 54% of countries are experiencing disruption to their malaria services as a result…
Read more
Tuberculosis
Call for proposals for evaluation of new TB diagnostics and testing strategies (FEND-TB)
ReadPandemic Preparedness
NOW CLOSED – Digital health solution providers to enable COVID RDT data capture
ReadPandemic preparedness
NOW CLOSED – Accelerating the availability of affordable SARS-CoV-2 self-tests
Readtest
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aliquam aspernatur, at blanditiis culpa ea et expedita iure iusto laboriosam laborum maiores minima modi nostrum nulla officia quibusdam repellendus suscipit voluptatibus!
test tes test test test ttdfs
R&D
Clinical trials
Access
Geneva, Switzerland (HQ)
Hanoi, Viet Nam
New Delhi, India
Cape Town, South Africa
Nairobi, Kenya
